NCT04082806View on ClinicalTrials.gov

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

GHB

50 mg/kg GHB at one experimental night

DRUG

Trazodone

1.5 mg/kg trazodone at one experimental night

DRUG

Placebos

placebo oral solution (placebo for GHB) and placebo pills (placebo for trazodon)

Trial Locations (1)

8032

Psychiatric University Hospital, Zurich

All Listed Sponsors
lead

Erich Seifritz

OTHER

NCT04082806 - Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder. | Biotech Hunter | Biotech Hunter